Article thumbnail

Evaluation of the stability of human erythropoietin in samples for radioimmunoassay

By Kai-Uwe Eckardt, Armin Kurtz, P. Hirth, P. Scigalla, L. Wieczorek and Christian Bauer

Abstract

Radioimmunoassays for erythropoietin are limited so far to a few specialized laboratories and this requires transport and storage of samples. We therefore tested the stability of immunoreactive erythropoietin in serum and plasma samples obtained from a uremic and a nonuremic anemic patient. No significant change in the concentration of immunoreactive erythropoietin was found in either serum or plasma samples for up to 14 days of storage. This type of stability was observed no matter whether the samples were stored at room temperature, 4 degrees C, or -20 degrees C. There was no difference between the estimates of erythropoietin in serum and heparinized plasma. Validity of the radioimmunoassay used in this study was demonstrated by parallelism of dilution curves of test specimens and the 2nd International Reference Preparation for erythropoietin and by a close correlation between the immunoreactivity and the bioactivity of the hormone, as assessed in the same samples by the exhypoxic polycythemic mouse bioassay. In conclusion the data obtained clearly indicate that the necessity of storage and transport of clinical samples does not limit the practicability of the radioimmunoassay for erythropoietin

Topics: 570 Biowissenschaften, Biologie, ddc:570, 610 Medizin, ddc:610
Publisher: 'Springer Fachmedien Wiesbaden GmbH'
Year: 1988
DOI identifier: 10.1007/bf01748163
OAI identifier: oai:epub.uni-regensburg.de:26997

Suggested articles

Citations

  1. (1981). A rationale for the application of trasylol as a protease inhibitor in radioimmunoassay. Life Sci 28:1861-1866 Received:
  2. (1982). An introduction to radioimmunoassay and related techniques, 2nd edn. Elsevier Biomedical,
  3. (1961). Bio-assay of erythropoietin in mice made polycythaemic by exposure to air at a reduced pressm'e.
  4. (1987). Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
  5. Cotes PM (i986) Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis.
  6. (1973). Effect of chemical and enzymatic agents on the biological activity of erythropoietin.
  7. (1987). Erythropoietin titers in anemic, nonuremic patients.
  8. (1982). Immunoreactive erythropoietin in serum.
  9. (1982). Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings.
  10. (1957). The mode of action and nature of a heat stable plasma erythropoietic factor.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.